Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis
Am J Hematol
.
2018 Sep;93(9):E235-E238.
doi: 10.1002/ajh.25203.
Epub 2018 Aug 31.
Authors
Mythri Mudireddy
1
,
Naseema Gangat
1
,
Terra L Lasho
1
,
Christy Finke
1
,
Curtis A Hanson
2
,
Rhett P Ketterling
2
,
Aneel A Ashrani
1
,
Animesh Pardanani
1
,
David M Nagorney
3
,
Ayalew Tefferi
1
Affiliations
1
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
2
Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.
3
Department of Surgery, Mayo Clinic, Rochester, Minnesota.
PMID:
29981287
DOI:
10.1002/ajh.25203
No abstract available
Publication types
Letter
MeSH terms
Adult
Aged
Aged, 80 and over
Anticoagulants / therapeutic use*
Female
Heparin / therapeutic use
Humans
Male
Middle Aged
Primary Myelofibrosis / surgery*
Splenectomy / methods*
Thrombosis / prevention & control*
Substances
Anticoagulants
Heparin